Imatinib in Adult Patients With Metastatic Ocular Melanoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Melanoma
Interventions
DRUG

Imatinib

800 mg/day until disease progression or toxicity

Trial Locations (12)

14076

Centre Francois Baclesse, Caen

21079

Centre Georges-Francois Leclerc, Dijon

31052

Institut Claudius Regaud, Toulouse

34298

Centre Val d'Aurelle Paul Lamarque, Montpellier

59020

Centre Oscar Lambret, Lille

59035

Centre Hospitalier Regional Universitaire, Lille

63011

Centre Jean Perrin, Clermont-Ferrand

67065

Centre Paul Strauss, Strasbourg

67098

Hopital Universitaire de Hautepierre, Strasbourg

69373

Centre Leon Berard, Lyon

75248

Institut Curie, Paris

94805

Centre Gustave Roussy, Villejuif

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

National Cancer Institute, France

OTHER_GOV

lead

Centre Oscar Lambret

OTHER